25 / 88
25
Sunday, 18 June 2017
/ Scientific Programme
WFSBP 2017
SUN
004
Omega-3 fatty acids, inflammation and depres-
sion: From biological mechanisms to clinical application
Kuan-Pin Su, Taiwan
FC-03
FREE COMMUNICATION SESSION
12:30–14:00
B3 M1-M2
Schizophrenia & dementia
Chair:
Alessandro Serretti, Italy
Co-Chair: Do-Hoon Kim, Republic of Korea
001
Clinical usefulness of the Screen for Cognitive
Impairment in Psychiatry (SCIP) in patients with schizo-
phrenia and affective disorder before and after cognitive
remediation
Andreas Erfurth, Austria
E. Maihofer, M. Neuwirth, H. Swoboda, G. Sachs
002
Association of plasma brain-derived neurotrophic
factor level with neurocognitive functions in patients
with at-risk mental state and first-episode psychosis
Kenji Sanada, Japan
S. Ruiz de Azúa, S. Mesa, S. Matsuzaki, A. Takahashi,
K. Saito, M. Martínez-Cengotitabengoa, A. Iwanami,
A. Gonzalez Pinto
003
The effects of Donepezil on Alzheimer's Diseased
(AD) rats' model with intestinal endotoxemia
Bai Han, People's Republic of China
F. Wu, C. Li, X. Shan, Q. Sun, K. Liu
004
Differential association of depression level with
cognitive function according to cognitive domains of
mild cognitve impairment and Alzheimer's Disease
Do-Hoon Kim, Republic of Korea
C. H. Lee, Y.-S. Moon
005
D-amino acid oxidase level in the peripheral blood
is higher in patients with age-related cognitive decline
Chieh-Hsin Lin, Taiwan
H.-Y. Lane
ES-01
EDUCATIONAL SESSION
14:00–17:00
B3 M3-M4
How to build an academic career
Chair:
Ida Hageman Pedersen, Denmark
001
How to get published
Gregers Wegener, Denmark
Søren Dinesen Østergaard, Denmark
002
How to combine research and clinical work
Klaus Munkholm, Denmark
003
How to combine research and clinical work
David Erritzoe, United Kingdom
004
How to get funded
Michael Berk, Australia
T39: PSYCHONEUROIMMUNOLOGY
S-09
SYMPOSIUM
14:30–16:00
Auditorium 10+11+12
Mechanisms contributing to neuroprogression in
psychiatric disorders and promising interventions
Chair:
Angelos Halaris, USA
001
Inflammatory and innate immune markers of
neuroprogression in depressed and teenage suicide
brain
Ghanshyam Pandey, USA
002
Major depression as a prelude to dementia: What
is the evidence?
Brian Leonard, Ireland
003
Neuroimaging of microglia activation in major
depression
Jeffrey Meyer, Canada
004
Promising neuroprotective and anti-inflammatory
interventions to arrest neuroprogression
Angelos Halaris, USA
T47: STIMULATION METHODS (ECT, TMS, VNS, DBS)
S-10
SYMPOSIUM
14:30–16:00
Auditorium 15
Effects and side effects of electroconvulsive therapy
Chair:
Michael Grözinger, Germany
Co-Chair: Helge Frieling, Germany
001
Effects of ECT on the oxygen saturation in the
frontal brain
Michael Grözinger, Germany
002
DNA methylation of P11 / S100A10: A putative
marker of response to ECT?
Helge Frieling, Germany
003
Electroconvulsive therapy enhances amyloid ß
1-42 in the cerebrospinal fluid of patients with major
depression
Alexander Sartorius, Germany
004
The EFFECT-Dep Trial (ISRCTN23577151):
Immediate and long-term cognitive outcomes
Declan McLoughlin, Ireland